| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/13/2006 | US20060154860 Manipulating stem-progenitor cell trafficking to injured tissue and/or tumors by altering HIF-1 and/or SDF-1 activity |
| 07/13/2006 | US20060154859 Leptin antagonists |
| 07/13/2006 | US20060154858 Canine rankl and methods for preparing and using the same |
| 07/13/2006 | US20060154857 G1 phase arresting compound is rapamycin and the HIV antiviral agent is T20 (enfuvirtide); enhances the activity of the antiviral agent |
| 07/13/2006 | US20060154856 NADPH oxidase inhibition pharmacotherapies for Obstructive Sleep Apnea syndrome and its associated morbidities |
| 07/13/2006 | US20060154855 Methods and compositions for beta conglycinin fraction of soy protein |
| 07/13/2006 | US20060154854 Molecules for targeting and releasing therapeutic compounds, and the use thereof |
| 07/13/2006 | US20060154853 Method of treating an autoimmune disease |
| 07/13/2006 | US20060154852 Beta sheet tapes ribbons in tissue engineering |
| 07/13/2006 | US20060154337 Gene encoding chondroitinase ABC and uses therefor |
| 07/13/2006 | US20060154333 Pan-HER antagonists and methods of use |
| 07/13/2006 | US20060154331 Erythrocyte differentiation factor, gene encoding same, and methods of use thereof |
| 07/13/2006 | US20060154330 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 07/13/2006 | US20060154319 Inhibition of bradykinin release |
| 07/13/2006 | US20060154295 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
| 07/13/2006 | US20060154294 Interleukin-18 binding proteins, their preparation and use |
| 07/13/2006 | US20060154293 Regulation of human prostasin-like serine protease |
| 07/13/2006 | US20060154291 Reagents and methods useful for detecting diseases of the breast |
| 07/13/2006 | US20060154271 Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR |
| 07/13/2006 | US20060154258 Card-domain containing polypeptides, encoding nucleic acids, and methods of use |
| 07/13/2006 | US20060154243 Antigenic peptides of SARS coronavirus and uses thereof |
| 07/13/2006 | US20060153926 Compositions, products and methods for controlling weight in a mammal |
| 07/13/2006 | US20060153912 Choline ascorbate formulations |
| 07/13/2006 | US20060153906 Pharmaceutical product for endonasal administration for treating central nervous system disease and disorders |
| 07/13/2006 | US20060153897 Zinc-containing foods |
| 07/13/2006 | US20060153896 Methods and devices for improving biofixation of implantable vascular devices |
| 07/13/2006 | US20060153894 Multi-compartment delivery system |
| 07/13/2006 | US20060153893 Therapeutic composition for bone infectious disease |
| 07/13/2006 | US20060153884 can be associated with the peptide 111-136 of HARP; cancer treatment |
| 07/13/2006 | US20060153879 Streptococcal C5a peptidase vaccine |
| 07/13/2006 | US20060153877 Remedies for dissease with hypermyotonia |
| 07/13/2006 | US20060153876 Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease |
| 07/13/2006 | US20060153867 To modulate the activity of one or more protein kinase C isozymes |
| 07/13/2006 | US20060153865 Antigenic peptides |
| 07/13/2006 | US20060153864 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 07/13/2006 | US20060153862 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
| 07/13/2006 | US20060153861 BCR-ABL imatinib resistance-associated peptides and methods of use thereof |
| 07/13/2006 | US20060153858 Drug delivery of a liquid comprising an antigen such as tumor-associated antigen directly to an area of high lymphatic drainage or a lymphatic system of the mammal to induce an antigen-specific Cytotoxic T lymphocyte (CTL) response; sustained release |
| 07/13/2006 | US20060153853 Cancers of the breast, prostate, colorectal, lung, thyroid, ovaries, and brain as well as in childhood leukaemias, glioblastomas, and neuroblastomas; Insulin-like Growth Factor Binding Protein (IGFBP) with reduced IGF (Insulin-like Growth Factor) release characteristics |
| 07/13/2006 | US20060153849 Methods of treatment with an antibody that suppresses growth differentiation factor-14 activity |
| 07/13/2006 | US20060153848 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/13/2006 | US20060153842 Immunosuppressive combination and its use in the treatment or prophylaxis or insulin-producing cell graft rejection |
| 07/13/2006 | US20060153841 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 07/13/2006 | US20060153839 Production of bispecific molecules using polyethylene glycol linkers |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153836 Using monoclonal antibody specific for kidney injury-molecule-1 (KIM-1) to diagnose, prevent and treat cell proliferative and kidney disorders; immunotherapeutics |
| 07/13/2006 | US20060153832 Immunomodulating polymers |
| 07/13/2006 | US20060153831 Antithrombosis enzyme from the snake venom of Agkistrodon acutus |
| 07/13/2006 | US20060153830 Proteases from Carica having mitogenic activity and their methods of use |
| 07/13/2006 | US20060153829 Stable formulations of purified proteins |
| 07/13/2006 | US20060153828 Plasmid-specific polypeptide found in Eschericha; splitting esterase inhibitor; antibodies |
| 07/13/2006 | US20060153827 Chimeric protein |
| 07/13/2006 | US20060153826 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 07/13/2006 | US20060153825 Use of protein histidine phosphatase |
| 07/13/2006 | US20060153824 Methods and kits for co-administration of nutritional supplements |
| 07/13/2006 | US20060153823 Compositions and methods for nutritional supplementation |
| 07/13/2006 | US20060153803 administering a combination of genetic engineered interferon and ribavirin to in vitro cells capable of being infected with RNA viruses; prevention of severe acute respiratory syndrome (SARS) |
| 07/13/2006 | US20060153802 Mammalian chemokine reagents |
| 07/13/2006 | US20060153801 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 07/13/2006 | US20060153800 DNA immunization with recombinase/transposase |
| 07/13/2006 | US20060153799 Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders |
| 07/13/2006 | US20060153798 Methods and compositions for needleless delivery of macromolecules |
| 07/13/2006 | US20060153797 Tissue material and matrix |
| 07/13/2006 | US20060153794 Hair tonics and method of screening the same |
| 07/13/2006 | US20060153791 Mixture of protein polymer and active materials |
| 07/13/2006 | US20060153778 Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
| 07/13/2006 | US20060153770 Method of treating tumors |
| 07/13/2006 | US20060151900 solid (cyclosporine, gemfibrozil or fenofibrate) melts under pressure of gas without degrading at temperature lower than melting point, forming solution with carrier, passing through vessel of lower pressure to form particles; encapsulated with biodegradable polyoxyethylene glycol, cellulose acetate |
| 07/13/2006 | US20060151574 Formulations useful against hepatitis C virus infections |
| 07/13/2006 | CA2603676A1 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds |
| 07/13/2006 | CA2599594A1 Use of glp-1 and agonists thereof to prevent cardiac myocyte apoptosis |
| 07/13/2006 | CA2594363A1 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 07/13/2006 | CA2594023A1 Igf-i fusion polypeptides and therapeutic uses thereof |
| 07/13/2006 | CA2593713A1 X-ray structure of human fpps and use for selecting fpps binding compounds |
| 07/13/2006 | CA2593682A1 Glycopegylated granulocyte colony stimulating factor |
| 07/13/2006 | CA2592943A1 Use of il-22 for the treatment of conditions of metabolic disorders |
| 07/13/2006 | CA2592888A1 Pharmaceutically active antiviral peptides |
| 07/13/2006 | CA2592877A1 Local treatment of bone defects with matrix releasing bmp or pth |
| 07/13/2006 | CA2592292A1 Sustained delivery of pdgf using self-assembling peptide nanofibers |
| 07/13/2006 | CA2590462A1 Methods for expression and purification of recombinant human growth hormone |
| 07/13/2006 | CA2589700A1 Modulators of alpha-synuclein toxicity |
| 07/13/2006 | CA2588644A1 Inhibition of li expression in mammalian cells |
| 07/13/2006 | CA2588026A1 Methods and compositions for rna interference |
| 07/13/2006 | CA2587310A1 Tripeptide and tetrapeptide sulfones |
| 07/13/2006 | CA2587284A1 Tripeptide and tetrapeptide thioethers |
| 07/13/2006 | CA2566507A1 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 07/12/2006 | EP1679376A2 Recombinant adenovirus comprising a chimeric penton base protein |
| 07/12/2006 | EP1679372A1 Novel plexin polypeptide, dna encoding the same and use thereof |
| 07/12/2006 | EP1679320A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 07/12/2006 | EP1679319A1 Methods for Preventing and Treating Alzheimer´s Disease (AD) |
| 07/12/2006 | EP1679081A2 Therapeutic application of cephaibols |
| 07/12/2006 | EP1679080A2 Prevention and treatment of amyloidogenic disease |
| 07/12/2006 | EP1679065A1 Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1678497A2 Methods and compositions for modulating apoptosis |
| 07/12/2006 | EP1678305A2 Protozoan strains of reduced virulence and use thereof |
| 07/12/2006 | EP1678303A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 07/12/2006 | EP1678302A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 07/12/2006 | EP1678297A1 Method for producing gamma-carboxylated proteins |
| 07/12/2006 | EP1678207A1 Regulation of matrix metalloproteinases by psp94 family members |